Advancements in Clinical Chemistry: Shifting from Conventional Techniques to Modern Technologies: A Narrative Review

Abstract

Background: Clinical chemistry has undergone a major transformation from conventional manual and semi-manual analytical techniques to automated, molecular, point-of-care, and artificial intelligence-enabled diagnostic systems. Traditional methods such as colorimetry, titrimetry, gravimetry, flame emission spectrophotometry, atomic absorption spectroscopy, manual microscopy, and manual centrifugation established the foundations of laboratory medicine but were limited by low throughput, operator dependence, prolonged turnaround time, and reduced sensitivity for low-abundance biomarkers. Objective: This narrative review aimed to examine the evolution of clinical chemistry from conventional diagnostic approaches to modern technologies and to evaluate their implications for laboratory efficiency, diagnostic accuracy, turnaround time, accessibility, quality assurance, and clinical decision-making. Methods: A narrative literature review was conducted using peer-reviewed English-language articles and authoritative laboratory medicine sources identified from PubMed, Google Scholar, ScienceDirect, and SpringerLink. Literature addressing traditional clinical chemistry methods, total laboratory automation, molecular diagnostics, point-of-care testing, biosensors, microfluidics, artificial intelligence, quality assurance, and regulatory considerations was synthesized thematically. Because of the heterogeneity of technologies, study designs, and outcomes, findings were summarized narratively rather than through quantitative pooling. Results: The synthesis showed that automation improves sample traceability, workflow integration, throughput, and result validation, while molecular diagnostics enhance sensitivity, specificity, and rapid pathogen or biomarker detection. Point-of-care testing reduces diagnostic delays and expands access in emergency, remote, and decentralized settings, although performance depends on assay type, operator training, and quality control. Artificial intelligence offers additional value in workload prediction, automated quality monitoring, critical result detection, and decision support, but requires validation, transparency, bias monitoring, and regulatory oversight. Conclusion: Modern clinical chemistry is shifting toward faster, more precise, integrated, and patient-centered diagnostics. Successful implementation requires not only technological adoption but also standardized quality assurance, workforce training, regulatory governance, cost-effective infrastructure, and continuous validation.